Safety of Early Discontinuation of Antiseizure Medication After Acute Symptomatic Neonatal Seizures

IMPORTANCE: Antiseizure medication (ASM) treatment duration for acute symptomatic neonatal seizures is variable. A randomized clinical trial of phenobarbital compared with placebo after resolution of acute symptomatic seizures closed early owing to low enrollment. OBJECTIVE: To assess whether ASM di...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:JAMA Neurol
Autori principali: Glass, Hannah C., Soul, Janet S., Chang, Taeun, Wusthoff, Courtney J., Chu, Catherine J., Massey, Shavonne L., Abend, Nicholas S., Lemmon, Monica, Thomas, Cameron, Numis, Adam L., Guillet, Ronnie, Sturza, Julie, McNamara, Nancy A., Rogers, Elizabeth E., Franck, Linda S., McCulloch, Charles E., Shellhaas, Renée A.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Medical Association 2021
Soggetti:
Original Investigation
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8145161/
https://ncbi.nlm.nih.gov/pubmed/34028496
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaneurol.2021.1437
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi